文献速递胃肠外科肝胆胰外科围术期管理与 ERAS

局部进展期右半结肠癌行胰十二指肠切除术的系统评价

Pancreaticoduodenectomy outcomes for locally advanced right colon cancers: A systematic review.
PubMed 文献 · Surgery · 2019-06-07

该系统评价基于27篇文献共106例患者,评估整块胰十二指肠切除联合右半结肠切除治疗局部进展期右半结肠癌的安全性与结局。结果显示R0切除率95.5%,并发症发生率52.4%,中位生存168个月,淋巴结转移是唯一独立预后因素。

要点

  • 整块PD联合RH治疗局部进展期右半结肠癌虽罕见但可行,R0切除率95.5%。
  • 术后并发症发生率52.4%,5年生存率66.3%,需权衡手术风险。

核心结论

  • 整块胰十二指肠切除联合右半结肠切除虽罕用于局部进展期右半结肠癌,但可能是潜在安全的治疗选择。
  • 淋巴结受累是唯一独立预后因素。

研究设计与样本

  • 系统评价,检索PubMed数据库,共纳入27篇文献106例患者(含本机构1例)。

主要发现

  • 患者以男性为主(62.1%),中位年龄58岁(范围34-83岁)。
  • 手术方式包括整块RH联合PD(n=91,85.8%)和保留幽门PD(n=15,14.2%)。
  • 可评估患者中R0切除率95.5%(n=63)。
  • 33例(52.4%)报告至少一种并发症,术后死亡3例。
  • 中位生存168个月,2年生存率75.9%,5年生存率66.3%。

关键数值与推荐

  • IIC期5年生存率84.9%,IIIC期46.4%。

临床怎么用

  • 对精心选择的局部进展期右半结肠癌患者,可考虑整块PD联合RH以达到R0切除。
  • 术前应评估淋巴结状态,因其为独立预后因素。
  • 需充分告知患者术后并发症风险较高(52.4%)。

局限性

  • 文献报道罕见,样本量小(106例),证据级别有限。
  • 系统评价基于回顾性病例报告和小样本研究,存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pancreaticoduodenectomy (PD) with right hemicolectomy (RH) to treat locally advanced right colon cancer (LARCC) has been rarely reported in the literature. Herein, we characterize clinicopathologic factors and evaluate outcomes of en bloc PD and RH for LARCC. METHODS: A systematic review of the literature was conducted on PubMed using MeSH terms ("pancreaticoduodenectomy" or "pancreas/surgery" or "duodenum/surgery" or "colectomy") and ("colonic neoplasms"). Data was extracted from patients who underwent en bloc PD and RH for LARCC. Factors investigated included patient demographics, surgical and pathologic parameters, postoperative complications, disease recurrence, and survival. RESULTS: Our search yielded 27 articles (106 patients), including 1 case from our institution. Most patients were male (62.1%), median age 58 years (range 34-83). Surgical procedures performed included en bloc RH with PD (n = 91, 85.8%) and en bloc RH with pylorus-preserving PD (n = 15, 14.2%). Among reported, 95.5% of patients (n = 63), underwent R0 resection. One or more complications were reported in 33 patients (52.4%). Median survival was 168 months. Survival after resection was 75.9% at 2 years and 66.3% at 5 years. Overall survival was greater in patients with no lymph node involvement (IIC versus IIIC, hazard ratio 8.4, P = .003). Five-year survival for patients was 84.9% in patients with stage IIC versus 46.4% in patients with stage IIIC. There were 3 postoperative mortalities. CONCLUSION: This data demonstrates that en bloc PD and RH is rarely performed yet can be a potentially safe treatment option in patients with LARCC. Lymph node involvement was the only independent prognostic factor.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Khalili M, Daniels L, Gleeson EM, et al. Pancreaticoduodenectomy outcomes for locally advanced right colon cancers: A systematic review. Surgery. 2019. PMID: 31182232. doi:10.1016/j.surg.2019.04.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。